Literature DB >> 11406530

Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother.

M G Paggi1, A Giordano.   

Abstract

This review portrays an updated overview about the possible tumor suppressive properties of the Rb2/p130 gene, the third member of the retinoblastoma (RB) family of genes, including RB itself and p107. After a brief analysis of the established structural and functional similarities among the three genes, the main purpose is to critically analyze present evidence whether Rb2/p130 shares the role of a tumor suppressor. Taking into account the well-proven growth suppressive properties of Rb2/p130 and p107, we discuss the analysis of mutated or deleted forms of Rb2/p130 found in a number of human cancers. Finally, we take into consideration the data provided by the targeted disruption of each RB family gene, alone or in combination, in the mouse model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406530

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

Review 1.  Human retinoblastoma binding protein 9, a serine hydrolase implicated in pancreatic cancers.

Authors:  Sergey M Vorobiev; Yuanpeng Janet Huang; Jayaraman Seetharaman; Rong Xiao; Thomas B Acton; Gaetano T Montelione; Liang Tong
Journal:  Protein Pept Lett       Date:  2012-02       Impact factor: 1.890

2.  Transcriptional gene expression profiles of HGF/SF-met signaling pathway in colorectal carcinoma.

Authors:  Xue-Nong Li; Yan-Qing Ding; Guo-Bing Liu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

3.  Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells.

Authors:  James G Jackson; Olivia M Pereira-Smith
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 4.  G1 to S phase cell cycle transition in somatic and embryonic stem cells.

Authors:  Irina Neganova; Majlinda Lako
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

Review 5.  Cell cycle kinases as therapeutic targets for cancer.

Authors:  Silvia Lapenna; Antonio Giordano
Journal:  Nat Rev Drug Discov       Date:  2009-07       Impact factor: 84.694

6.  Simian immunodeficiency virus Nef protein delays the progression of CD4+ T cells through G1/S phase of the cell cycle.

Authors:  Thomas Ndolo; Navdeep K Dhillon; Hau Nguyen; Moraima Guadalupe; Maria Mudryj; Satya Dandekar
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells.

Authors:  Nicola Alessio; Wolfgang Bohn; Verena Rauchberger; Flavio Rizzolio; Marilena Cipollaro; Michael Rosemann; Martin Irmler; Johannes Beckers; Antonio Giordano; Umberto Galderisi
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

Review 8.  The retinoblastoma tumor-suppressor gene, the exception that proves the rule.

Authors:  D W Goodrich
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

9.  Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.

Authors:  Yan Li; Bo Tian; Jiong Yang; Lei Zhao; Xin Wu; Sheng-Long Ye; Yin-Kun Liu; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-05-14       Impact factor: 4.553

10.  pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda.

Authors:  Sam Kalungi; Solrun J Steine; Henry Wabinga; Leif Bostad; Anders Molven
Journal:  BMC Clin Pathol       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.